Beth Brooks
University of British Columbia(CA)BC Children's Hospital(CA)
Publications by Year
Research Areas
Hearing, Cochlea, Tinnitus, Genetics, Lung Cancer Research Studies, Ear and Head Tumors, Plant Molecular Biology Research, Cancer therapeutics and mechanisms
Most-Cited Works
- → Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy(2009)326 cited
- → Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium(2019)136 cited
- → Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children(2013)128 cited
- → Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study(2021)79 cited
- Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.(2006)
- → Ototoxicity monitoring in children treated with platinum chemotherapy(2017)68 cited
- → Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer(2017)49 cited
- → The cumulative incidence of cisplatin‐induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments(2021)42 cited
- → A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy(2019)40 cited
- → Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients(2018)38 cited